In the realm of public health, few viruses have commanded as much attention and concern as HIV, or human immunodeficiency virus. Since its discovery in the 1980s, HIV has posed significant challenges ...
Results from early-stage trial show that 80% of participants who received one of two HIV vaccine candidates produced antibodies against viral proteins. Two vaccine candidates using mRNA technology ...
May 16 (Reuters) - (To receive the full newsletter in your inbox for free sign up here) The first human clinical trials testing a new strategy to protect against HIV infections have yielded promising ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback